Cellular biology and evidence

NAD+: what the biology and treatment evidence mean

Learn what NAD+ is, why it is a coenzyme rather than a peptide, how routes and precursors differ, and what to ask about IV or injectable preparation quality.

What should I know about NAD+?

NAD+, or nicotinamide adenine dinucleotide, is a coenzyme involved in cellular metabolism. Its biological importance does not itself prove that a particular infusion, injection, or supplement improves longevity or symptoms. Route-specific human evidence and preparation quality must be considered separately.

Explore the guides

Common NAD+ questions

Is NAD+ a peptide?

No. NAD+ is a coenzyme, not a chain of amino acids. Its appearance alongside peptide services does not make it a peptide or establish that evidence for one treatment applies to the other.

Are NAD+, NR, and NMN the same substance?

No. Nicotinamide riboside and nicotinamide mononucleotide are related precursors studied in NAD metabolism, but they are different substances. Evidence for one substance and route should not be treated as proof for another.

Do NAD+ studies prove an anti-aging benefit?

A biological rationale or change in a laboratory marker does not establish improved longevity or a meaningful clinical outcome. Examine the specific human study, route, comparison, sample size, and follow-up before interpreting a claim.

What should I ask about injectable NAD+ quality?

The FDA has warned about ingredients unsuitable for sterile compounding, including food-grade NAD+ used in IV products. Ask about the exact preparation, pharmacy, sterile-compounding quality, and how potential adverse effects are handled.

Prepare for the next conversation

Use the consultation checklist and cost worksheet to organize your questions. A licensed clinician must determine whether a specific treatment is appropriate.

Primary sources

By the PacificRx editorial team. Educational information, not individualized medical advice.